Jinhe Biotechnology Co. Ltd.
Jinhe Biotechnology,
a joint stock company based in Inner Mongolia, P.R. China, boasts the largest fermentation capacity in the world dedicated
to the manufacture of the key animal health molecules, chlortetracycline feed grade, chlortetracycline hydrochloride and salinomycin.
The production facility comprises of 4,400 m3 fermentation vessel capacity monitored by the
most advanced automated process control and quality control laboratories. This capacity permits us to adapt individual product
capacity to ensure consistent product supply to satisfy our customers’ needs.
The
plant comes with a 21 year history and substantial investments in plant, process control and quality systems resulting in
the company being awarded its first Veterinary Master File by the US FDA in 1994. A second Veterinary Master File was granted
in 2007. It qualified for ISO 9001:2000 certification in 2001, as well as Chinese and Australian GMP certifications in 2002.